Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Enlimomab

Next Previous
X
Search
Drug Profile

Enlimomab

Alternative Names: BIRR 0001; BIRR 1; Murine anti-CD54 monoclonal antibody; Murine anti-ICAM-1 monoclonal antibody; R6 5 D6; R6.5; RR1; RR1/1

Latest Information Update: 18 Dec 2001

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Boehringer Ingelheim
  • Class Monoclonal antibodies
  • Mechanism of Action Immunosuppressants; Intercellular adhesion molecule-1 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Asthma; Autoimmune disorders; Burns; Diabetes mellitus; Graft-versus-host disease; Intracranial thrombosis; Liver transplant rejection; Myocardial ischaemia; Renal transplant rejection; Rheumatoid arthritis; Stroke

Most Recent Events

  • 18 Dec 2001 A study has been added to the adverse events and Neurological Disorders therapeutic trials sections
  • 10 May 1999 Results of a clinical study were added to the adverse events and therapeutic trials sections
  • 03 Feb 1999 A study has been added to the Neurological disorders pharmacodynamics section

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top